Fortress Biotech, Inc. (FBIOP) Return on Sales (2015 - 2026)
Fortress Biotech (FBIOP) posted quarterly Return on Sales of 0.0% for Q4 2025, up 1.0% year-over-year from 0.0% in Q4 2024, and down 185.45% quarter-over-quarter from 0.01% in Q3 2025.
Fortress Biotech, Inc. (FBIOP) Return on Sales (2015 - 2026) Analysis & Trends
Fortress Biotech's Return on Sales history runs 11 years deep, the most recent figure standing at 0.0% for Q4 2025.
- In Q4 2025, Return on Sales rose 1.0% year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, up 2.0% from the prior year.
- Return on Sales for Q4 2025 stood at 0.0%, down from 0.01% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q4 2022, with the low at 3.05% in Q2 2023.
- The 5-year median for Return on Sales is 0.03% (2021), against an average of 0.48%.
- The sharpest annual moves came in 2023 and 2024: Return on Sales slumped 302 bps in 2023, then jumped 303 bps in 2024.
- Fortress Biotech's Return on Sales stood at 0.01% in 2021, then jumped by 198 bps to 0.01% in 2022, then tumbled by 290 bps to 0.02% in 2023, then climbed by 9 bps to 0.02% in 2024, then jumped by 75 bps to 0.0% in 2025.
- Business Quant data shows FBIOP's Return on Sales at 0.0% in Q4 2025, 0.01% in Q3 2025, and 0.03% in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.03% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.59% |
| Jun 30, 2023 | -3.05% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | -1.46% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.86% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -2.93% |